Singapore markets closed

Repare Therapeutics Inc. (RPTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.84+0.23 (+1.57%)
At close: 04:00PM EDT
14.16 -0.68 (-4.58%)
After hours: 06:04PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close14.61
Bid14.90 x 1400
Ask15.50 x 1000
Day's range13.71 - 14.87
52-week range8.06 - 35.75
Avg. volume870,833
Market cap621.71M
Beta (5Y monthly)0.92
PE ratio (TTM)N/A
EPS (TTM)-3.08
Earnings date10 Aug 2022 - 15 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est34.11
  • Business Wire

    Repare Therapeutics to Participate at the Goldman Sachs 43rd Annual Global Healthcare Conference

    CAMBRIDGE, Mass. & MONTREAL, June 07, 2022--Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on Tuesday, June 14, 2022 at 03:20 p.m. Pacific Time/ 6:20 p.m. Eastern Time in Rancho Palos Verdes, CA.

  • Zacks

    Repare (RPTX) Up 20% on Deal With Roche for Solid Tumor Drug

    Repare Therapeutics (RPTX) signs a licensing agreement with Roche (RHHBY) to develop its lead candidate for solid tumor indications.

  • Motley Fool

    Why Repare Therapeutics Stock Is Skyrocketing Today

    After the market closed Wednesday, Repare Therapeutics (NASDAQ: RPTX) announced that it had entered into a licensing and collaboration deal with Roche (OTC: RHHBY) for its experimental cancer drug, camonsertib, also known as RP-3500. In the wake of that news, Repare shares skyrocketed, and were up by 36.5% as of 11:58 a.m. ET on Thursday. The spectacular gain for Repare Thursday seems to be warranted, especially in light of the details of its agreement with the Swiss healthcare giant.